ArticleFrontiers in pharmacology2024

Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles.

Yuxuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.